Top

65 -- Pentostam

Active

2008-Q-49482Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The Centers for Disease Control and Prevention (CDC) plans to issue a sole source purchase order valued at $31,764 to GlaxoSmithKline in the United Kingdom for Sodium Stibogluconate (Pentostam), a drug distributed under FDA Investigational New Drug Application Number 84831. CDC has determined that GlaxoSmithKline is the only supplier capable of meeting the requirements, as no other sources exist within the United States. This procurement is conducted under FAR subpart 13.106-1(b), which permits sole sourcing due to the unique availability of the product. Potential interested parties who believe they can provide the drug or related services are invited to submit a capabilities statement within 15 days from the announcement date. Such submissions will be reviewed solely to determine whether a competitive procurement process is warranted, with the final decision resting at the discretion of the CDC. Documentation can be sent by fax or email to the designated contract specialist, Ronnie E Francis. The solicitation is identified under number 2008-Q-49482, linked to NAICS code 423450, and the CDC retains the right to proceed without competition based on all responses received.

General Info

CDC to sole source $31,764 purchase of unique drug Sodium Stibogluconate from GlaxoSmithKline UK.

Agency

N/A

NAICS

423450 - Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

Place of Performance

Not specified

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedNov 8

special-notice

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyN/A

Contacts2 people available

OfficeN/A

Organization / Agency

N/A

Office AddressN/A

Contacts

Ronnie E FrancisContract Specialist

Patrick W Gourley

Full Description

In accordance with FAR subpart 13.106-1(b) the Centers for Disease Control and Prevention (CDC) intends to issue a sole source purchase order to GlaxoSmithKline, Brentford, Middlesex, UNITED KINGDOM, in the amount of $31,764.00 for the purchase of Sodium Stibogluconate (Pentostam). CDC believes that GlaxoSmithKline is the only organization that can meet the requirements of the order because there is no other source in the U.S. for this drug. This drug is distributed under U. S. Food and Drug Administration (FDA) Investigational New Drug (IND) Application Number 84831. Interested parties who feel that they possess the capabilities to provide this service described above should submit a capabilities statement demonstrating their abilities to provide the service. The information received in response to this notice will be considered solely for the purpose of determining whether or not to conduct a competitive procurement. Please send your documentation to Ronnie Francis at the office identified above, by fax (770) 488-2688 or by e-mail to efi8@cdc.gov. Documentation should be received within fifteen (15) days after the date of publication of this synopsis to be considered by CDC. A determination by the CDC not to compete this proposed contract based upon responses to this notice is solely within discretion of the government.